Trial
NCT04617847
Open-label Extension Study to Evaluate the Safety and Tolerability of WVE-120101 in Patients With Huntington's Disease
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Wave Life Sciences USA, Inc.
Collaborators
—
Condition
Huntington Disease
Intervention
WVE-120101
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-09